== Side effects ==

 
In clinical trials, the most common side effect was [[headache]], experienced by about 18% of drug arm participants compared to 11% of placebo participants. Headache was the only reported side effect to occur at a frequency greater than 5 percentage points above those from placebo. Other reported side effects and their rates for lorcaserin and placebo patients, respectively, were as follows: [[upper respiratory tract infection]] (14.8% vs. 11.9%), [[nasopharyngitis]] (13.4% vs. 12.0%), [[sinusitis]] (7.2% vs. 8.2%), and [[nausea]] (7.5% vs. 5.4%). Adverse events of [[Depression (mood)|depression]], [[anxiety]], and [[suicidal ideation]] were infrequent and were reported at a similar rate in each treatment group.
